Hypoadrenocorticism can only be treated medically and consists of replacing the missing hormones aldosterone and cortisol with synthetic hormones that have similar efficacy. There are no alternative treatment methods and once initiated, treatment will have to be administered for the rest of the animal’s life.
Zycortal is a prolonged-release suspension used as replacement therapy for mineralocorticoid deficiency in dogs with primary hypoadrenocorticism. It is the only veterinary licensed mineralocorticoid replacement therapy in Europe. Zycortal contains the active ingredient is desoxycortone pivalate (DOCP), a pure mineralocorticoid hormone which regulates electrolyte and water balance. As DOCP has minimal glucocorticoid activity – dogs will need daily glucocorticoid, such as Prednicortone®, alongside periodic Zycortal injections.
For further information on how to best use Zycortal in practice, please refer to the SPC alongside Dechra’s 5 Golden Guidelines